Revance Therapeutics’ $200 Million Common Stock Offering

Cooley represented Revance, while Morgan Lewis represented Goldman Sachs & Co. LLC, Cowen and Company LLC, and Guggenheim Securities LLC, as joint book-running managers in the…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Laura Testa

Author: Laura Testa

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here